Measuring informed choice in population-based reproductive genetic screening: A systematic review

European Journal of Human Genetics

Volumn 23, Issue 1, 2015, Pages 8-21

  Ames, Alice Grace ^a,b   Metcalfe, Sylvia Ann ^a,b   Archibald, Alison Dalton ^a,b,c   Duncan, Rony Emily ^b,d   Emery, Jon ^b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c VICTORIAN CLINICAL GENETICS SERVICES   (Australia)

^d MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATTITUDE; BEHAVIOR; CONFLICT; DECISION MAKING; FRAGILE X SYNDROME; GENETIC SCREENING; HUMAN; KNOWLEDGE; PERSONAL VALUE; POPULATION GENETICS; PRENATAL SCREENING; PRIORITY JOURNAL; SYSTEMATIC REVIEW; ATTITUDE TO HEALTH; DOWN SYNDROME; GENETICS; HETEROZYGOTE; MASS SCREENING; META ANALYSIS; REPRODUCTION;

CHOICE BEHAVIOR; DECISION MAKING; DOWN SYNDROME; GENETIC TESTING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HETEROZYGOTE; HUMANS; MASS SCREENING; REPRODUCTION;

EID: 84926980439     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2014.89     Document Type: Article

References (80)

1. Khoury MJ, McCabe LL, McCabe ERB: Genomic medicine - Population screening in the age of genomic medicine. N Engl J Med 2003; 348: 50-58.
2. Godard B, ten Kate L, Evers-Kiebooms G, Ayme S: Population genetic screening programmes: principles, techniques, practices, and policies. Eur J Hum Genet 2003; 11: S49-S87.
3. World Health Organisation: Proposed International Guidelines on Ethical Issues in Medical Genetics and Genetic Services. Geneva, 1998.
4. Brehaut JC, O'Connor AM, Wood TJ et al: Validation of a decision regret scale. Med Decis Making 2003; 23: 281-292.
5. Wertz D, Fletcher J, Berg K, Boulyjenkov V: Guidelines on ethical issues in medical genetics and the provision of genetics services, Hereditary Diseases Program, Division of Noncommunicable DiseasesGeneva: World Health Organisation, 1995.
6. Kohut RJ, Dewey D, Love EJ: Women's knowledge of prenatal ultrasound and informed choice. J Genet Counsel 2002; 11: 265-276.
7. Bekker H, Thornton JG, Airey CM et al: Informed decision making: an annotated bibliography and systematic review. Health Technol Assess 1999; 3: 1-156.
8. Briss P, Rimer B, Reilley B et al: Promoting informed decisions about cancer screening in communities and healthcare systems. Am J Prev Med 2004; 26: 67-80.
9. Rimer BK, Briss PA, Zeller PK, Chan ECY, Woolf SH: Informed decision making: what is its role in cancer screening? Cancer 2004; 101: 1214-1228.
10. O'Connor AM: Validation of a decisional conflict scale. Med Decis Making 1995; 15: 25-30.
11. van den Berg M, Timmermans DRM, ten Kate LP, van Vugt JMG, van der Wal G: Informed decision making in the context of prenatal screening. Patient Educ Couns 2006; 63: 110-117.
12. Marteau TM, Dormandy E, Michie S: A measure of informed choice. Health Expect 2001; 4: 99-108.
13. van den Berg M, Timmermans DRM, Ten Kate LP, van Vugt JMG, van der Wal G: Are pregnant women making informed choices about prenatal screening? Genet Med 2005; 7: 332-338.
14. Jepson RG, Hewison J, Thompson AGH, Weller D: How should we measure informed choice? The case of cancer screening. J Med Ethics 2005; 31: 192-196.
15. Irwig L, McCaffery K, Salkeld G, Bossuyt P: Informed choice for screening: implications for evaluation. Br Med J 2006; 332: 1148-1150.
16. Mullen PD, Allen JD, Glanz K et al: Measures used in studies of informed decision making about cancer screening: a systematic review. Ann Behav Med 2006; 32: 188-201.
17. Foundation for Genetics and Population Health. Glossary of genetics terminology. 2012 (cited 08/09/2013); URL. http://www.phgfoundation.org/pages/resources/glossary.htm
18. Rostant K, Steed L, O'Leary P: Survey of the knowledge, attitudes and experiences of Western Australian women in relation to prenatal screening and diagnostic procedures. Aust N Z J Obstet Gynaecol 2003; 43: 134-138.
19. De Vigan C, Vodovar V, Goujard J, Garel M, Vayssière C, Goffinet F: Mothers' knowledge of screening for trisomy 21 in 1999: a survey in Paris maternity units. Eur J Obstet Gynecol Reprod Biol 2002; 104: 14-20.
20. Dahl K, Hvidman L, Jørgensen FS et al: First-trimester Down syndrome screening: pregnant women's knowledge. Ultrasound Obstet Gynecol 2011; 38: 145-151.
21. Glazier R, Goel V, Holzapfel S, Summers A, Pugh P, Yeung M: Written patient information about triple-marker screening: a randomized, controlled trial. Obstet Gynecol 1997; 90: 769-774.
22. Goel V, Glazier R, Holzapfel S, Pugh P, Summers A: Evaluating patient's knowledge of maternal serum screening. Prenat Diagn 1996; 16: 425-430.
23. Kaiser AS, Ferris LE, Pastuszak AL et al: The effects of prenatal group genetic counselling on knowledge, anxiety and decisional conflict: issues for nuchal translucency screening. J Obstet Gynaecol 2002; 22: 246-255.
24. Smith DK, Shaw RW, Marteau TM: Informed consent to undergo serum screening for Down's syndrome: the gap between policy and practice. Br Med J 1994; 309: 776.
25. Tschudin S, Huang D, Mor-Gultekin H, Alder J, Bitzer J, Tercanli S: Prenatal counseling-implications of the cultural background of pregnant women on information processing, emotional response and acceptance. Eur J Ultrasound 2011; 32:(Suppl 2) E100-E107.
26. Brown K, Dormandy E, Reid E, Gulliford M, Marteau T: Impact on informed choice of offering antenatal sickle cell and thalassaemia screening in primary care: a randomized trial. J Med Screen 2011; 18: 65-75.
27. Dormandy E, Bryan S, Gulliford MC et al: Antenatal screening for haemoglobinopathies in primary care: a cohort study and cluster randomised trial to inform a simulation model. The Screening for Haemoglobinopathies in First Trimester (SHIFT) trial. Health Technol Assess 2010; 14: 1-160.
28. Kuppermann M, Norton ME, Gates E et al: Computerized prenatal genetic testing decision-assisting tool: a randomized controlled trial. Obstet Gynecol 2009; 113: 53-63.
29. Michie S, Smith D, McClennan A, Marteau TM: Patient decision making: an evaluation of two different methods of presenting information about a screening test. Br J Health Psychol 1997; 2: 317-326.
30. Miedzybrodzka ZH, Hall MH, Mollison J et al: Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise v couple screening. Br Med J 1995; 310: 353-357.
31. Nagle C, Gunn J, Bell R et al: Use of a decision aid for prenatal testing of fetal abnormalities to improve women's informed decision making: a cluster randomised controlled trial. Br J Obstet Gynaecol 2008; 115: 339-347.
32. O'Cathain A, Walters SJ, Nicholl JP, Thomas KJ, Kirkham M: Use of evidence based leaflets to promote informed choice in maternity care: randomised controlled trial in everyday practice. Br Med J 2002; 324: 643-646.
33. Graham W, Smith P, Kamal A, Fitzmaurice A, Smith N, Hamilton N: Randomised controlled trial comparing effectiveness of touch screen system with leaflet for providing women with information on prenatal tests. Br Med J 2000; 320: 155-160.
34. Hewison J, Cuckle H, Baillie C et al: Use of videotapes for viewing at home to inform choice in Down syndrome screening: a randomised controlled trial. Prenat Diagn 2001; 21: 146-149.
35. Dormandy E, Michie S, Hooper R, Marteau TM: Informed choice in antenatal Down syndrome screening: a cluster-randomised trial of combined versus separate visit testing. Patient Educ Couns 2006; 61: 56-64.
36. Ames AG, Jaques A, Ukoumunne OC et al: Development of a fragile X syndrome (FXS) knowledge scale: towards a modified multidimensional measure of informed choice for FXS population carrier screening. Health Expect 2012; e-pub ahead of print 15 October 2012; doi:10.1111/hex.12009.
37. Chilaka VN, Konje JC, Stewart CR, Narayan H, Taylor DJ: Knowledge of Down syndrome in pregnant women from different ethnic groups. Prenat Diagn 2001; 21: 159-164.
38. Dahl K, Hvidman L, Jorgensen FS, Kesmodel US: Knowledge of prenatal screening and psychological management of test decisions. Ultrasound Obstet Gynecol 2011; 38: 152-157.
39. Dormandy E, Hooper R, Michie S, Marteau T: Informed choice to undergo prenatal screening: a comparison of two hospitals conducting testing either as part of a routine visit or requiring a separate visit. J Med Screen 2002; 9: 109-114.
40. Dormandy E, Michie S, Hooper R, Marteau TM: Low uptake of prenatal screening for Down syndrome in minority ethnic groups and socially deprived groups: a reflection of women's attitudes or a failure to facilitate informed choices? Int J Epidemiol 2005; 34: 346-352.
41. Dormandy E, Tsui EYL, Marteau TM: Development of a measure of informed choice suitable for use in low literacy populations. Patient Educ Couns 2007; 66: 278-295.
42. Farrell RM, Nutter B, Agatisa PK: Meeting patients' education and decision-making needs for first trimester prenatal aneuploidy screening. Prenat Diagn 2011; 31: 1222-1228.
43. Favre R, Moutel G, Duchange N et al: What about informed consent in first-trimester ultrasound screening for Down syndrome? Fetal Diagn Ther 2008; 23: 173-184.
44. Fransen MP, Essink-Bot ML, Vogel I, Mackenbach JP, Steegers EAP, Wildschut HIJ: Ethnic differences in informed decision-making about prenatal screening for Down's syndrome. J Epidemiol Community Health 2010; 64: 262-268.
45. Gourounti K, Sandal J: The validation and translation of Multidimensional Measure of Informed Choice in Greek. Midwifery 2011; 27: 170-173.
46. Gourounti K, Sandall J: Do pregnant women in Greece make informed choices about antenatal screening for Down's syndrome? A questionnaire survey. Midwifery 2008; 24: 153-162.
47. Hwa HL, Huang LH, Hsieh FJ, Chow SN: Informed consent for antenatal serum screening for Down syndrome. Taiwan J Obstet Gynecol 2010; 49: 50-56.
48. Jaques AM, Halliday JL, Bell RJ: Do women know that prenatal testing detects fetuses with Down syndrome? J Obstet Gynaecol 2004; 24: 647-651.
49. Jaques AM, Sheffield LJ, Halliday JL: Informed choice in women attending private clinics to undergo first-trimester screening for Down syndrome. Prenat Diagn 2005; 25: 656-664.
50. Metcalfe S, Jacques A, Archibald A et al: A model for offering carrier screening for fragile X syndrome to nonpregnant women: results from a pilot study. Genet Med 2008; 10: 525-535.
51. Michie S, Smith D, Marteau TM: Prenatal tests: how are women deciding? Prenat Diagn 1999; 19: 743-748.
52. Rowe HJ, Fisher JRW, Quinlivan JA: Are pregnant Australian women well informed about prenatal genetic screening? A systematic investigation using the Multidimensional Measure of Informed Choice. Aust N Z J Obstet Gynaecol 2006; 46: 433-439.
53. Stefansdottir V, Skirton H, Jonasson K, Hardardottir H, Jonsson JJ: Effects of knowledge, education, and experience on acceptance of first trimester screening for chromosomal anomalies. Acta Obstet Gynecol Scand 2010; 89: 931-938.
54. Watson EK, Mayall E, Chapple J et al: Screening for carriers of cystic fibrosis through primary health care services. Br Med J 1991; 303: 504-507.
55. Wynter KH, Rowe HJ, Fisher JR, Lee M, Quinlivan JA: Are adolescents' decisions about prenatal screening for Down syndrome informed? A controlled, prospective study. J Pediatr Adolesc Gynecol 2011; 24: 29-34.
56. Kuppermann M, Learman LA, Gates E et al: Beyond race or ethnicity and socioeconomic status: predictors of prenatal testing for Down syndrome. Obstet Gynecol 2006; 107: 1087-1097.
57. Ajzen I: The theory of planned behavior. Organ Behav Hum Decis Process 1991; 50: 179-211.
58. Green JM, Hewison J, Bekker HL, Bryant LD, Cuckle HS: Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review. Health Technol Assess 2004; 8: 1-128.
59. Bekker HL, Hewison J, Thornton JG: Understanding why decision aids work: linking process with outcome. Patient Educ Couns 2003; 50: 323-329.
60. Holmes-Rovner M, Kroll J, Schmitt N et al: Patient satisfaction with health care decisions: the satisfaction with decision scale. Med Decis Making 1996; 16: 58-64.
61. Tversky A, Kahneman D: Judgment under uncertainty: heuristics and biases. Science 1974; 185: 1124-1131.
62. Dawson NV, Weiss R: Dichotomizing continuous variables in statistical analysis. Med Decis Making 2012; 32: 225-226.
63. O'Connor AM, O'Brien-Pallas L: Decisional conflict (specify); in Mcfarland GK, Mcfarlane EA (eds) Nursing Diagnosis & Intervention: Planning for Patient Care. St Louis, MO: Mosby Incorporated, 1993; pp 468-478.
64. Archibald AD, Jaques AM, Wake S, Collins VR, Cohen J, Metcalfe SA: "It's something I need to consider": decisions about carrier screening for fragile X syndrome in a population of non-pregnant women. Am J Med Genet A 2009; 149A: 2731-2738.
65. Kasparian NA, Wakefield CE, Meiser B: Assessment of psychosocial outcomes in genetic counseling research: an overview of available measurement scales. J Genet Counsel 2007; 16: 693-712.
66. Bunnik EM, Janssens ACJ, Schermer MH: A tiered-layered-staged model for informed consent in personal genome testing. Eur J Hum Genet 2012; 21: 596-601.
67. Counsyl. Genetic testing as the first step to a healthy pregnancy. 2013 (cited 21 November 2013); URL: www.counsyl.com
68. General Medical Council: Consent: patients and doctors making decisions together. General Medical Council: London, 2008.
69. Deans Z, Newson A: Should non-invasiveness change informed consent procedures for prenatal diagnosis? Health Care Anal 2011; 19: 122-132.
70. van den Heuvel A, Chitty L, Dormandy E et al: Will the introduction of non-invasive prenatal diagnostic testing erode informed choices? An experimental study of health care professionals. Patient Educ Couns 2010; 78: 24-28.
71. Michie S, Dormandy E, Marteau TM: The multi-dimensional measure of informed choice: a validation study. Patient Educ Couns 2002; 48: 87-91.
72. General Medical Council: Consent: patients and doctors making decisions together. General Medical Council: London, 1998.
73. Marteau TM, Johnston M, Plenicar M, Shaw RW, Slack J: Development of a selfadministered questionnaire to measure women's knowledge of prenatal screening and diagnostic tests. J Psychosom Res 1988; 32: 403-408.
74. American College of Obstetricians and Gynecologists Committee. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 2007; 109: 217-227.
75. Farrell RM, Dolgin N, Flocke SA, Winbush V, Mercer MB, Simon C: Risk and uncertainty: shifting decision making for aneuploidy screening to the first trimester of pregnancy. Genet Med 2011; 13: 429-436.
76. Thornton JG, Hewison J, Lilford RJ, Vail A: A randomised trial of three methods of giving information about prenatal testing. Br Med J 1995; 311: 1127-1130.
77. Priest JH, FitzGerald JM, Haag MM, Streets K, Vanisko M, Johnson JP: Acceptance of amniocentesis by women in the state of Montana (USA) who are screen positive for Down's syndrome. J Med Screen 1998; 5: 178-182.
78. Houts PS, Bachrach R, Witmer JT, Tringali CA, Bucher JA, Localio RA: Using pictographs to enhance recall of spoken medical instructions. Patient Educ Couns 1998; 35: 83-88.
79. Houts PS, Witmer JT, Egeth HE, Loscalzo MJ, Zabora JR: Using pictographs to enhance recall of spoken medical instructions II. Patient Educ Couns 2001; 43: 231-242.
80. US National Cancer Institute. Simplification of Informed Consent Documents. 2006. URL: http://www.nci.nih.gov/clinicaltrials/understanding/simplification-of-informedconsent-docs.